Comparison of 90° and 120° Arm Positions in Costoclavicular Block
COSTO-RCT
Effect of Arm Abduction Degree ( 90° vs. 120° ) on Block Onset Time and Block Success in Costoclavicular Brachial Plexus Block in Patients Undergoing Hand, Wrist and Forearm Surgery: A Prospective Randomized Controlled Trial
1 other identifier
interventional
106
0 countries
N/A
Brief Summary
The costoclavicular approach of the infraclavicular brachial plexus block is widely used for upper extremity surgeries due to its reliable anatomy and high success rates. Patient positioning, particularly the degree of arm abduction, may influence the spread of local anesthetic and the characteristics of the block. However, the optimal arm abduction angle during this procedure remains unclear. This prospective randomized controlled trial aims to investigate the effect of two different arm abduction angles (90° and 120°) on block onset time and block success in patients undergoing hand, wrist, and forearm surgery under ultrasound-guided costoclavicular brachial plexus block. Patients will be randomly assigned to one of two groups according to the degree of arm abduction. The primary outcome is block onset time. Secondary outcomes include block success, sensory and motor block characteristics, perfusion index changes, hemodynamic parameters, readiness for surgery at 15 and 20 minutes, block performance time, need for additional anesthesia, postoperative neurological evaluation at 4 and 24 hours, complications, and patient satisfaction. The findings of this study are expected to provide evidence on optimal patient positioning to improve the effectiveness and reliability of ultrasound-guided costoclavicular brachial plexus block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 27, 2026
June 9, 2026
June 1, 2026
2 months
April 7, 2026
June 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Block Onset Time
Time from completion of local anesthetic injection to achievement of adequate sensory block sufficient for surgery, assessed by pinprick test.
Up to 30 minutes after block performance
Secondary Outcomes (16)
Block Success
İntraoperative period
Sensory Block Score
Baseline and at 5-minute intervals up to 20 minutes after block performance.
Motor Block Score
Baseline and at 5-minute intervals up to 30 minutes after block performance.
Perfusion Index
Baseline and at 5,10,15 and 20 minutes after block performance.
Readiness for Surgery
15 minutes after block
- +11 more secondary outcomes
Study Arms (2)
90° Arm Abduction
EXPERIMENTALPatients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 90° abduction.
120° Arm Abduction
EXPERIMENTALPatients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 120° abduction.
Interventions
Ultra-sound Guided costoclavicular brachial plexus block performed for upper extremity surgery using a standard local anesthetic technique
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 80 years.
- Patients scheduled for elective upper extremity surgery (hand, wrist, forearm).
- Patients classified as ASA I-III.
- Patients who provide informed consent after being informed about the study.
You may not qualify if:
- History of previous surgery, scar tissue, tumor, or trauma that may alter brachial plexus anatomy.
- Presence of infection, hematoma, severe edema, burn, or open wound at the block application site.
- Known allergy to local anesthetics or other medications used in the study.
- Coagulopathy, use of anticoagulants, or platelet count \< 100,000/mm³.
- History of peripheral neuropathy, neurological deficit, cervical radiculopathy, or CRPS.
- Pregnancy or breastfeeding.
- Patients with BMI \< 18 kg/m².
- Patients with BMI \> 35 kg/m².
- Severe cardiac, pulmonary, renal, or hepatic failure.
- Mental retardation, communication difficulties, or lack of cooperation.
- Deformity, amputation, or large mass in the surgical extremity that may interfere with sensorimotor assessment.
- Preoperative significant sensory loss, motor weakness, or signs of neurological disease.
- Severe anemia (Hb \< 9 g/dL) or polycythemia (Hb \> 18 g/dL).
- Psychiatric disorders, substance abuse, or any condition that may interfere with study compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Reyhan Polat, Professor
Ankara Etlik City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is an open-label trial. Due to the nature of the intervention (different arm positions), blinding is not feasible
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 7, 2026
First Posted
May 14, 2026
Study Start
May 15, 2026
Primary Completion (Estimated)
July 15, 2026
Study Completion (Estimated)
August 27, 2026
Last Updated
June 9, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share